| abstract |
In the present invention, there are disclosed derivatives of the general formula I, in which all the substituents have specific meanings. Process for preparing the derivatives is characterized by condensing the compound of the general formula III with 2,4-thiazolidinedione and the resulting compound can be optionally reduced. In the invention there is also claimed a pharmaceutical preparation intended for treating diabetes mellitus or hyperlipemia, whereby the pharmaceutical preparation comprises as active component the above specified thiazolidinedione derivative according to this invention. |